Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 RetrophinOmerosHomology MedicinesRocket PharmaceuticalsMallinckrodt
SymbolNASDAQ:RTRXNASDAQ:OMERNASDAQ:FIXXNASDAQ:RCKTNYSE:MNK
Price Information
Current Price$21.21$14.65$20.80$12.53$6.92
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$44.50$27.75$30.1250$31.40$20.5294
% Upside from Price Target109.81% upside89.42% upside44.83% upside150.60% upside196.67% upside
Trade Information
Market Cap$886.33 million$759.91 million$910.66 million$653.26 million$605.14 million
Beta0.933.040.162.72.32
Average Volume421,098396,450252,035527,0952,700,451
Sales & Book Value
Annual Revenue$164.25 million$29.87 million$3.68 millionN/A$3.22 billion
Price / Sales5.3524.06246.49N/A0.18
CashflowN/AN/AN/AN/A$17.7436 per share
Price / CashN/AN/AN/AN/A0.39
Book Value$7.72 per share($2.04) per share$5.19 per share$4.47 per share$34.66 per share
Price / Book2.75-7.184.01N/A0.20
Profitability
Net Income$-102,680,000.00$-126,760,000.00$-57,220,000.00$-74,520,000.00$-3,607,000,000.00
EPS($2.54)($2.22)($2.00)($1.89)$8.01
Trailing P/E Ratio0.000.000.00N/A0.90
Forward P/E RatioN/AN/AN/AN/A0.90
P/E GrowthN/AN/AN/AN/A$0.07
Net Margins-75.75%-241.81%-2,253.08%N/A-118.53%
Return on Equity (ROE)-41.38%N/A-34.90%-46.81%14.22%
Return on Assets (ROA)-19.39%-106.08%-27.37%-35.10%5.26%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.69%N/AN/A0.25%1.90%
Current Ratio4.57%1.73%10.80%9.70%1.45%
Quick Ratio4.52%1.71%10.80%9.70%1.08%
Ownership Information
Institutional Ownership PercentageN/A52.12%52.87%85.14%N/A
Insider Ownership Percentage4.32%12.10%33.40%41.40%2.70%
Miscellaneous
Employees214236124333,700
Shares Outstanding41.44 million49.06 million43.61 million50.29 million83.81 million
Next Earnings Date7/25/2019 (Estimated)8/8/2019 (Estimated)8/12/2019 (Estimated)8/14/2019 (Estimated)8/6/2019 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 RetrophinOmerosHomology MedicinesRocket PharmaceuticalsMallinckrodt

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel